The survey highlights a growing frustration among industry leaders, with 60 percent reporting that EPA review timelines now exceed one year. This bottleneck is directly impacting corporate decision-making, as two-thirds of respondents indicated that these delays are actively influencing where they choose to locate manufacturing facilities. Furthermore, 70 percent of surveyed firms have canceled projects entirely due to regulatory uncertainty, while every company experiencing delays reported a resulting postponement in product commercialization.
In section Releases
Manufacturers Link TSCA Reform to Domestic Reshoring Goals
Nearly 93 percent of chemical manufacturers argue that a more predictable review process under Section 5 of the Toxic Substances Control Act would drive domestic reshoring, according to new survey data from the Society of Chemical Manufacturers & Affiliates released ahead of the September 30 expiration of EPA user fee authority.
Jenn Klein, President and CEO of SOCMA, emphasized that the current regulatory friction undermines broader legislative goals regarding supply chain security and economic independence. Beyond general manufacturing, the delays are stalling the development of critical innovations, including PFAS alternatives and specialized chemistries for the pharmaceutical and semiconductor sectors. As Congress nears the deadline to reauthorize the program's user-fee structure, the industry is pushing for five specific reforms, including a return to timely reviews and increased transparency, to ensure that the regulatory environment supports rather than hinders domestic investment.
Comments (0)
No comments yet. Be the first!